Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
January 08 2021 - 5:23PM
Edgar (US Regulatory)
Filed by Cleveland BioLabs, Inc.
Pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934
Subject Company: Cleveland BioLabs, Inc.
(SEC File No. 001-32954)
Cytocom (NASDAQ:CBLI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cytocom (NASDAQ:CBLI)
Historical Stock Chart
From Apr 2023 to Apr 2024